SEC Form 4 · accession 0001133416-26-000065
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard E Uihlein
Director · 10% Owner
Period of report
Jul 31, 2026
Accepted (ET)
Aug 4, 2026 · 7:52 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 31, 2026 | M | 31,825,235 | $3.00 | A | 42,162,911 | I | Richard E. Uihlein Stock Trust |
| Common Stock | Jul 31, 2026 | M | 2,550,932 | $4.05 | A | 44,713,843 | I | Richard E. Uihlein Stock Trust |
| Common StockF4 | holding | — | — | — | 27,710 | I | By Ed Uihlein Family Foundation |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Line of Credit Convertible NotesF1,F3 | $3.00 | Jul 31, 2026 | M | — | D | Dec 19, 2022 | Jun 30, 2027 | Common Stock | 31,825,235 | 0 | I |
| Line of Credit Convertible NotesF2,F3 | $4.05 | Jul 31, 2026 | M | — | D | Dec 31, 2025 | Jun 30, 2027 | Common Stock | 2,550,932 | 0 | I |
Explanation of responses
- F1Consists of $91,000,000 in principal and $14,475,705 in accrued interest.
- F2Consists of $10,000,000 of principal and $331,275 of accrued interest.
- F3The Line of Credit Convertible Notes are exercisable upon issuance when the issuer draws on the Line of Credit. Notes were issued on December 19, 2022; March 31, 2023; June 30, 2023; December 29, 2023; March 29, 2024; June 28, 2024; September30, 2024; April 30, 2025; June 30, 2025 and December 31, 2025. There was no expiration date; however, the maturity date of all Line of Credit Convertible Notes was June 30, 2027.
- F4The reporting person is president and director of Ed Uihlein Family Foundation, a not-for-profit corporation. The reporting person has no pecuniary interest in the shares, however, he shares voting and dispositive power over the shares and, therefore, remains the beneficial owner of the shares solely for the purposes of Section 13(d) of the Securities Exchange Act of 1934.